Yazji Salim
Insider CIK 1864486 · ONCT Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ONCT Oncternal Therapeutics, In | A Award deriv | 2024-02-14 | 2024-02-15 | 14,200 | — | $0 | 14,200 | SEC↗ |
| ONCT Oncternal Therapeutics, In | F Tax w/h | 2024-01-03 | 2024-01-05 | 19,742 | $0.50 | $9.9K | 128,635 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 354,400 | — | $0 | 354,400 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 210,000 | — | $0 | 210,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 92,075 | — | $0 | 92,075 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 70,600 | — | $0 | 70,600 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 210,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 55,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 92,075 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 354,400 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | F Tax w/h | 2023-07-03 | 2023-07-05 | 16,299 | $0.36 | $5.9K | 148,377 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2023-04-14 | 2023-04-14 | 5,000 | $0.30 | $1.5K | 164,676 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2023-04-13 | 2023-04-14 | 10,000 | $0.29 | $2.9K | 159,676 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2023-04-12 | 2023-04-14 | 10,000 | $0.29 | $2.9K | 149,676 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-02-21 | 2023-02-23 | 210,000 | — | $0 | 210,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | F Tax w/h | 2023-01-03 | 2023-01-05 | 9,961 | $1.02 | $10.2K | 139,676 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2022-07-28 | 2022-08-01 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award | 2022-07-28 | 2022-08-01 | 82,500 | — | $0 | 149,637 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2022-01-27 | 2022-01-31 | 10,000 | $1.69 | $16.9K | 67,137 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2022-01-20 | 2022-01-24 | 92,075 | — | $0 | 92,075 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award | 2022-01-03 | 2022-01-05 | 57,137 | — | $0 | 57,137 | SEC↗ |